Why you shouldn’t overlook Canadian IP litigation

While Canada is known for its natural resources and universal healthcare, it is often overlooked as a jurisdiction to litigate IP disputes.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Merchant & Gould hires 13 attorneys to open new Boston office

6 January 2026 The new recruits from a boutique Boston firm enables Merchant to expand and strengthen its tech and life sciences offering in the innovation hub.

Asia

Novo Nordisk secures China win ahead of key patent expiration

6 January 2026 Danish pharma giant notches an important victory in a huge market for semaglutide, but faces a patent cliff and mounting challenges across India, Canada and the US.

Europe

Edwards v Meril: Inside the UPC’s landmark medtech showdown

6 January 2026 As Edwards secures another win against its rival, LSIPR talks to Siddharth Kusumakar—partner at Powell Gilbert and counsel for the winning party.

More features

Key EU and UK regulatory changes to watch for in 2026

Regeneron v Alvotech: The big impact

Beyond traditional IP: A comprehensive AI strategy for life sciences

Prosecuting bispecific antibody patents: A cookbook for patent chefs

EU Pharma Package hits the final stretch—but can negotiators agree?

The clinical trial dilemma: Navigating European practice

Still Unsettling: The uncertain landscape for discretionary denial

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order

Why you shouldn’t overlook Canadian IP litigation

More on this story

Editor's picks

Editor's picks

More features